Skip to main content
Epidemiology and Infection logoLink to Epidemiology and Infection
. 1988 Feb;100(1):153–156. doi: 10.1017/s095026880006564x

HTLV-1, HIV-1, hepatitis B and hepatitis delta in the Pacific and South-East Asia: a serological survey.

R J Brindle 1, R P Eglin 1, A J Parsons 1, A V Hill 1, J B Selkon 1
PMCID: PMC2249211  PMID: 2892692

Abstract

Blood samples from 13 locations in the Pacific and South-East Asia were tested for evidence of infection with human T-cell lymphotropic virus type-1 (HTLV-1), human immunodeficiency virus (HIV-1), hepatitis B virus (HBV) and hepatitis delta virus (HDV). No samples were positive for antibody to HIV-1. Antibodies to HTLV-1 were found in samples from five locations, the maximum prevalence being 19%, in Vanuatu. Serological markers of HBV infection were found in all locations, the maximal prevalence being 88%, in Majuro, Micronesia. Antibodies to HDV in HBsAg positive sera were found in six locations with a maximum prevalence of 81% in Kiribati.

Full text

PDF
153

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aoki T., Miyakoshi H., Koide H., Yoshida T., Ishikawa H., Sugisaki Y., Mizukoshi M., Tamura K., Misawa H., Hamada C. Seroepidemiology of human T-lymphotropic retrovirus type I (HTLV-I) in residents of Niigata Prefecture, Japan. Comparative studies by indirect immunofluorescence microscopy and enzyme-linked immunosorbent assay. Int J Cancer. 1985 Mar 15;35(3):301–306. doi: 10.1002/ijc.2910350304. [DOI] [PubMed] [Google Scholar]
  2. Dimitrakakis M., Crowe S., Gust I. Prevalence of delta infection in the western Pacific region. J Med Virol. 1986 Apr;18(4):335–339. doi: 10.1002/jmv.1890180406. [DOI] [PubMed] [Google Scholar]
  3. Gessain A., Barin F., Vernant J. C., Gout O., Maurs L., Calender A., de Thé G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985 Aug 24;2(8452):407–410. doi: 10.1016/s0140-6736(85)92734-5. [DOI] [PubMed] [Google Scholar]
  4. Gust I. D., Lehmann N. I., Dimitrakakis M. A seroepidemiologic study of infection with HAV and HBV in five Pacific Islands. Am J Epidemiol. 1979 Sep;110(3):237–242. doi: 10.1093/oxfordjournals.aje.a112808. [DOI] [PubMed] [Google Scholar]
  5. Hadler S. C., De Monzon M., Ponzetto A., Anzola E., Rivero D., Mondolfi A., Bracho A., Francis D. P., Gerber M. A., Thung S. Delta virus infection and severe hepatitis. An epidemic in the Yucpa Indians of Venezuela. Ann Intern Med. 1984 Mar;100(3):339–344. doi: 10.7326/0003-4819-100-3-339. [DOI] [PubMed] [Google Scholar]
  6. Hawkes R. A., Boughton C. R., Ferguson V., Vale T. G. The seroepidemiology of hepatitis in Papua New Guinea. II. A long-term study of hepatitis B. Am J Epidemiol. 1981 Oct;114(4):563–573. doi: 10.1093/oxfordjournals.aje.a113222. [DOI] [PubMed] [Google Scholar]
  7. Hinuma Y., Chosa T., Komoda H., Mori I., Suzuki M., Tajima K., Pan I. H., Lee M. Sporadic retrovirus (ATLV)-seropositive individuals outside Japan. Lancet. 1983 Apr 9;1(8328):824–825. doi: 10.1016/s0140-6736(83)91885-8. [DOI] [PubMed] [Google Scholar]
  8. Ishida T., Yamamoto K., Omoto K., Iwanaga M., Osato T., Hinuma Y. Prevalence of a human retrovirus in native Japanese: evidence for a possible ancient origin. J Infect. 1985 Sep;11(2):153–157. doi: 10.1016/s0163-4453(85)92099-7. [DOI] [PubMed] [Google Scholar]
  9. Kuo T. T., Chan H. L., Su I. J., Eimoto T., Maeda Y., Kikuchi M., Chen M. J., Kuan Y. Z., Chen W. J., Sun C. F. Serological survey of antibodies to the adult T-cell leukemia virus-associated antigen (HTLV-A) in Taiwan. Int J Cancer. 1985 Sep 15;36(3):345–348. [PubMed] [Google Scholar]
  10. Lingao A. L., Domingo E. O., West S., Reyes C. M., Gasmen S., Viterbo G., Tiu E., Lansang M. A. Seroepidemiology of hepatitis B virus in the Philippines. Am J Epidemiol. 1986 Mar;123(3):473–480. doi: 10.1093/oxfordjournals.aje.a114262. [DOI] [PubMed] [Google Scholar]
  11. Ponzetto A., Forzani B., Parravicini P. P., Hele C., Zanetti A., Rizzetto M. Epidemiology of hepatitis delta virus (HDV) infection. Eur J Epidemiol. 1985 Dec;1(4):257–263. doi: 10.1007/BF00237100. [DOI] [PubMed] [Google Scholar]
  12. Rodgers-Johnson P., Gajdusek D. C., Morgan O. S., Zaninovic V., Sarin P. S., Graham D. S. HTLV-I and HTLV-III antibodies and tropical spastic paraparesis. Lancet. 1985 Nov 30;2(8466):1247–1248. doi: 10.1016/s0140-6736(85)90778-0. [DOI] [PubMed] [Google Scholar]
  13. Wong D. C., Purcell R. H., Rosen L. Prevalence of antibody to hepatitis A and hepatitis B viruses in selected populations of the South Pacific. Am J Epidemiol. 1979 Sep;110(3):227–236. doi: 10.1093/oxfordjournals.aje.a112807. [DOI] [PubMed] [Google Scholar]
  14. Zaninović V. Spastic paraparesis: a possible sexually transmitted viral myeloneuropathy. Lancet. 1986 Sep 20;2(8508):697–698. doi: 10.1016/s0140-6736(86)90217-5. [DOI] [PubMed] [Google Scholar]

Articles from Epidemiology and Infection are provided here courtesy of Cambridge University Press

RESOURCES